SOCIETY FOR CLINICAL TRIALS INC (EIN 521151889) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1979

Legal Domicile

Principal Officer

KEVIN BRAGAW

Phone

8474278010

Tax Period

2023-01-01 to 2023-12-31

SOCIETY FOR CLINICAL TRIALS INC, founded in 1979, is a small nonprofit in the Medical Research sector that reported $680K in total revenue in fiscal year 2023. Revenue surged 32% from the prior year, signaling strong growth momentum. Expenses of $593K left a modest 13% surplus.

Mission

TO DEVELOP AND DRIVE ADOPTION OF PRACTICES THAT WILL INCREASE THE QUALITY AND EFFICIENCY OF CLINICAL TRIALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $58,332

Program Service Revenue $614,865

Investment Income $7,053

Other Revenue $0

TOTAL REVENUE $680,250

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $444,107

Other Expenses $593,016

TOTAL EXPENSES $593,016

Year-over-Year Comparison

	2023	2022	Change
Revenue	$680,250	$513,678	+0.3%
Expenses	$593,016	$617,372	0.0%
Net Income	$87,234	$-103,694	-1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DIXIE ECKLUND	PRESIDENT	15.00	Officer Director	$0	$0	$0
SCOTT R EVANS	PRESIDENT ELECT	5.00	Officer Director	$0	$0	$0
LEHANA THABANE	PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
MICHAELY GRAYLING	SECRETARY	5.00	Officer Director	$0	$0	$0
CHRISTOPHER COFFEY	TREASURER	5.00	Officer Director	$0	$0	$0
KALEAB ABEBE	DIRECTOR	2.00	Director	$0	$0	$0
JODY CIOLINO	DIRECTOR	2.00	Director	$0	$0	$0
JONATHAN COOK	DIRECTOR	2.00	Director	$0	$0	$0
DENISE ESSERMAN	DIRECTOR	2.00	Director	$0	$0	$0
ELIZABETH GARRETT-MAYER	DIRECTOR	2.00	Director	$0	$0	$0
MASHA KOCHERGINSKY	DIRECTOR	2.00	Director	$0	$0	$0
THEODORE LYSTIG	DIRECTOR	2.00	Director	$0	$0	$0
LETITIA H PERDUE	DIRECTOR	2.00	Director	$0	$0	$0
JULIANA TOLLES	DIRECTOR	2.00	Director	$0	$0	$0
KEVIN BRAGAW	EXECUTIVE DIRECTOR	10.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$680,250	$593,016	$349,729	$87,234
2022	$513,678	$617,372	$248,945	$-103,694
2021	$350,739	$374,520	$349,533	$-23,781
2020	$161,036	$267,874	$385,319	$-106,838
2019	$564,066	$584,883	$421,585	$-20,817
2018	$500,371	$505,179	$468,795	$-4,808

SOCIETY FOR CLINICAL TRIALS INC